Pacific Biosciences of California, Inc. (PACB) Stock

Pacific Biosciences of California, Inc. (PACB) is a Technology stock trading at $1.39 (as of 2026-06-18), with a market capitalization of $462.80M and a trailing P/E of -3.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Pacific Biosciences of California, Inc. develops and manufactures DNA sequencing systems and related consumables used for real-time sequencing workflows. Its offerings include sequencing instruments, SMRT cells, and reagent and kit products for preparing and running assays, serving research institutions, commercial laboratories, genome centers, public health and clinical organizations, and pharmaceutical and agricultural customers.

Valuation — source: SEC EDGAR (first-party)
Price	$1.39
Market Cap	$462.80M
P/E Ratio	-3.6
EV / EBITDA	-3.3
Price / Book	195.60
Price / Sales	2.89
DCF Value (model)	$-6.21
DCF Upside vs Price	-546.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$160.00M
Net Margin	-341.5%
Return on Equity	-5434.3%
Current Ratio	5.65
Revenue Growth (YoY)	0.1%
EPS Growth (YoY)	-97.9%
FCF Growth (YoY)	5.0%

Financial Health — source: SEC EDGAR
Altman Z-Score	-6.15 (distress)

Valuation vs Sector & Industry
Stock P/E	-3.6
Sector P/E (Technology)	32.6
Industry P/E (Measuring & Control Equipment)	60.1
vs Sector	-111.1%
vs Industry	-106.1%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	ARK Investment Management LLC ($47.88M)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Measuring & Control Equipment
CEO	Christian O. Henry
Employees	575
Country	US
IPO Date	2010-10-27

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.